Reduction of severe visual loss and complications following intra-arterial chemotherapy (IAC) for refractory retinoblastoma | British Journal of Ophthalmology

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via AAO

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via AAO

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

Article metrics

Clinical science

Reduction of severe visual loss and complications following intra-arterial chemotherapy (IAC) for refractory retinoblastoma

Online download statistics by month:

Online download statistics by month: April 2017 to December 2020

	Abstract	Full	Pdf
Apr 2017	377	22	23
May 2017	285	38	21
Jun 2017	148	14	8
Jul 2017	58	6	5
Aug 2017	39	8	4
Sep 2017	118	4	2
Oct 2017	286	18	6
Nov 2017	370	38	19
Dec 2017	388	74	36
Jan 2018	426	49	21
Feb 2018	108	18	3
Mar 2018	96	19	9
Apr 2018	69	21	10
May 2018	134	13	5
Jun 2018	70	14	3
Jul 2018	70	17	3
Aug 2018	76	16	4
Sep 2018	63	17	2
Oct 2018	68	13	2
Nov 2018	83	10	3
Dec 2018	37	9	0
Jan 2019	41	16	3
Feb 2019	63	16	7
Mar 2019	26	3	3
Apr 2019	13	3	2
May 2019	36	8	4
Jun 2019	34	10	0
Jul 2019	35	10	2
Aug 2019	60	14	3
Sep 2019	43	14	2
Oct 2019	26	10	5
Nov 2019	26	11	1
Dec 2019	29	14	0
Jan 2020	25	9	0
Feb 2020	34	13	3
Mar 2020	16	9	2
Apr 2020	36	14	2
May 2020	54	15	1
Jun 2020	16	8	0
Jul 2020	43	12	2
Aug 2020	19	11	1
Sep 2020	32	14	1
Oct 2020	36	16	4
Nov 2020	30	1	1
Dec 2020	49	3	0
Total	4191	692	238